In this issue:
Perioperative nivolumab ±ipilimumab in resectable HCC
MWA vs. resection for HCC within the Milan criteria
Impact of additional margin radiofrequency coagulation in liver resection with subcentimetric margin
Hepatectomy for MAFLD-related HCC
Long-term outcomes of deceased donor liver transplantation in HCC with portal vein tumour thrombus
Survival outcomes of CHC vs. ICC
GALAD for HCC surveillance of patients with cirrhosis
Controversial risk factors for cholangiocarcinoma
Atezolizumab + bevacizumab in advanced HCC
Clinical characteristics, treatments and healthcare costs/utilisation for HCC in the US
Please login below to download this issue (PDF)